An Introduction to SuperShot® PRP
An Introduction to SuperShot® PRP By Dr. Mark Katakowski, Ph.D. President & Chief Science Officer Forever Labs Since we launched SuperShot® we have had tremendous interest in the ability to concentrate extracellular vesicles (EVs) in platelet-rich plasma (PRP) therapy. As a research scientist, I have been studying the therapeutic value of mesenchymal stem cells for 20 years, and exosomes for 10 years, and have developed therapies and filed patents employing both. Several years ago, I became aware of the use of PRP in orthobiologics and began to study and experiment with PRP systems and techniques. Based upon my research experience with exosomes, it struck me that these potent biological molecules were not being leveraged in PRP therapies that included them but...